Normal1 The head of the http://bit.ly/2uIeYzo" Shock, Organic Dysfunction and Resuscitation Research Group (SODIR) of the Vall d'Hebron Research Institute (VHIR) is the new Vice President of the http://bit.ly/1zvhRlx" Spanish Society of Intensive, Critical Medicine and Coronary Units (SEMICYUC). The appointment of Dr. Ricard Ferrer was made effective on June 20, at the assembly of the entity. The new board is led by Dr. Mari Cruz Martín Delgado, of the University Hospital of Torrejón, to whom Dr. Ferrer will replace the post in 2019. Normal1 The new vice president of SEMICYUC says that "it is exciting to spend some time and effort in trying to make it grow." At the same time, he trusts that the work of the board of directors and his presidency, within two years, will help "to give critical patients the best assistance from motivated and excellently prepared professionals." Normal1 For Dr. Ferrer, the intensive medicine specialty is "in full maturity" and lives a moment of "generational spare." Also, "there are many specialties interested in the critical patient and this implies that we must make an additional effort to be the reference of these serious patients." The new period that SEMICYUC initiates also faces a talent drain to other countries with better working conditions, and the aging of equipment caused by the economic crisis. Normal1 Adapt to new technologies Normal1 The fact that the hospital centres focus more and more on the acute and serious patients causes that, according to the Dr. Ferrer, intensive medicine is becoming "a specialty of the future." But "many changes are approaching new technologies that will lead to a change of paradigm, telemedicine, big data, artificial intelligence, the automation of many tasks," and this forces specialists to prepare themselves "for this future, that is already coming, without leaving out empathy with patients and their families." Normal1 Dr. Ricard Ferrer Normal1 Dr. Ricard Ferrer is the head of the Vall d'Hebron http://bit.ly/1922rX2" Intensive Care Service since September 2016 and coordinator of the VHIR's Shock, Organic Dysfunction and Resuscitation Research group (SODIR). He holds a degree in Medicine and Surgery from the University of Barcelona and his areas of interest include severe sepsis and septic shock, nocosomial infections and acute respiratory distress syndrome. Normal1 He is the principal investigator or co-investigator in more than 20 clinical trials and author or co-author in more than 90 indexed publications. He is also coordinator of the Research Network Edusepsis, a researcher at the CIBER Respiratory Diseases and a representative of the State at the Council of the European Society of Intensive Care Medicine (ESICM). At the same time, he is a member of the Scientific Committee of the Life-Priority Foundation ESICM and of the Steering Committee and the Scientific Committee of the Surviving Sepsis Campaign.